Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash from Operations (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Cash from Operations for 3 consecutive years, with 1077761.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 4.59% to 1077761.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5850255.0 through Dec 2025, down 20.28% year-over-year, with the annual reading at 5850255.0 for FY2025, 20.28% down from the prior year.
  • Cash from Operations hit 1077761.0 in Q4 2025 for Mangoceuticals, up from 1241264.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 991131.0 in Q1 2024 to a low of 2274781.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 1475950.5 across 3 years, with a median of 1416842.5 in 2024.
  • Biggest five-year swings in Cash from Operations: soared 45.19% in 2024 and later crashed 129.51% in 2025.
  • Year by year, Cash from Operations stood at 1697741.0 in 2023, then skyrocketed by 33.47% to 1129575.0 in 2024, then grew by 4.59% to 1077761.0 in 2025.
  • Business Quant data shows Cash from Operations for MGRX at 1077761.0 in Q4 2025, 1241264.0 in Q3 2025, and 1256449.0 in Q2 2025.